Vivimed Labs Limited (VIVIMEDLAB)

Volume: 37,894Avg Vol 1W: 80,279.2Avg Vol 1M: 1,01,147.252W Range:₹5.15₹8.85

₹6.7▼ 2.33%

Key Ratios

Market Cap₹52 Cr

Current Price₹6.7

Previous Close₹6.86

High / Low (52w)₹8.85 / ₹5.15

Volume37,894

Avg Vol (1W)80,279.2

Avg Vol (1M)1,01,147.2

Stock P/E—

Book Value₹-5.79

Dividend Yield0%

ROE50.8%

ROA-3.8%

Revenue (TTM)₹121 Cr

Revenue Growth-22%

Profit Margin-41.8%

Total Debt₹64 Cr

Shares Outstanding8 Cr

Face Value₹2

EPS (TTM)₹-2

P/B0

Debt / Equity-8.01

50 DMA₹6.85

200 DMA₹6.93

Day change-2.33%

Price Chart

₹6.7▼ 11.49% · 1Y

2026-02-09

2026-05-11

20-day avg volume: 1.0L shares

Pros

Cons

Quarterly Results

Metric	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	₹39 Cr	₹29 Cr	₹25 Cr	₹37 Cr	₹26 Cr	₹21 Cr	₹21 Cr	₹16 Cr
EBITDA	₹-27 Cr	₹-15 Cr	₹-5 Cr	₹-5 Cr	₹-4 Cr	₹-5 Cr	₹-6 Cr	₹-16 Cr
Net Profit	₹5 Cr	₹-15 Cr	₹-5 Cr	₹-6 Cr	₹-6 Cr	₹-5 Cr	₹-7 Cr	₹-17 Cr
EPS	—	—	—	—	—	—	—	—

Profit & Loss (Annual)

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Revenue	₹1,067 Cr	₹871 Cr	₹239 Cr	₹188 Cr	₹159 Cr	₹121 Cr
EBITDA	₹-51 Cr	₹-16 Cr	₹-25 Cr	₹-295 Cr	₹-43 Cr	₹-29 Cr
Net Profit	₹-109 Cr	₹-72 Cr	₹-68 Cr	₹-329 Cr	₹-45 Cr	₹-32 Cr
EPS	—	—	—	—	—	—

Balance Sheet

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Assets	₹2,210 Cr	₹1,289 Cr	₹1,266 Cr	₹995 Cr	₹951 Cr	₹921 Cr
Total Liabilities	₹1,375 Cr	₹858 Cr	₹902 Cr	₹956 Cr	₹956 Cr	₹956 Cr
Equity	₹835 Cr	₹432 Cr	₹364 Cr	₹39 Cr	₹-5 Cr	₹-35 Cr
Total Debt	₹470 Cr	₹58 Cr	₹61 Cr	₹62 Cr	₹64 Cr	₹64 Cr

Cash Flow

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Operating	₹100 Cr	₹542 Cr	₹28 Cr	₹35 Cr	₹-24 Cr	₹-2 Cr
Investing	₹-196 Cr	₹404 Cr	₹-16 Cr	₹-5 Cr	₹28 Cr	₹-5 Cr
Financing	₹72 Cr	₹-1,015 Cr	₹-10 Cr	₹-34 Cr	₹-6 Cr	₹5 Cr
Free Cash Flow	₹100 Cr	₹542 Cr	₹28 Cr	₹35 Cr	₹-24 Cr	₹-2 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search